Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
93,227,509
-
Total 13F shares
-
75,763,137
-
Share change
-
+778,388
-
Total reported value
-
$2,201,774,533
-
Put/Call ratio
-
228%
-
Price per share
-
$29.07
-
Number of holders
-
254
-
Value change
-
+$4,437,682
-
Number of buys
-
128
-
Number of sells
-
118
Institutional Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q4 2018
As of 31 Dec 2018,
MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) was held by
254 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
75,763,137 shares.
The largest 10 holders included
BlackRock Inc., BAILLIE GIFFORD & CO, Vanguard Group Inc, D. E. Shaw & Co., Inc., STATE STREET CORP, FRONTIER CAPITAL MANAGEMENT CO LLC, DIMENSIONAL FUND ADVISORS LP, Consonance Capital Management LP, ACADIAN ASSET MANAGEMENT LLC, and NORTHERN TRUST CORP.
This page lists
255
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.